These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7590780)

  • 1. Antiidiotype induction therapy: evidence for the induction of immune response through the idiotype network in patients with ovarian cancer after administration of anti-CA125 murine monoclonal antibody B43.13.
    Madiyalakan R; Sykes TR; Dharampaul S; Sykes CJ; Baum RP; Hör G; Noujaim AA
    Hybridoma; 1995 Apr; 14(2):199-203. PubMed ID: 7590780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-idiotype induction therapy: anti-CA125 antibodies (Ab3) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab1).
    Schultes BC; Baum RP; Niesen A; Noujaim AA; Madiyalakan R
    Cancer Immunol Immunother; 1998 Jun; 46(4):201-12. PubMed ID: 9671143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological responses to the tumor-associated antigen CA125 in patients with advanced ovarian cancer induced by the murine monoclonal anti-idiotype vaccine ACA125.
    Wagner U; Schlebusch H; Köhler S; Schmolling J; Grünn U; Krebs D
    Hybridoma; 1997 Feb; 16(1):33-40. PubMed ID: 9085126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13--evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo.
    Noujaim AA; Schultes BC; Baum RP; Madiyalakan R
    Cancer Biother Radiopharm; 2001 Jun; 16(3):187-203. PubMed ID: 11471484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antiidiotypic antibody ACA 125 mimicking the tumor-associated antigen CA 125 for immunotherapy of ovarian cancer.
    Schlebusch H; Wagner U; Grünn U; Schultes B
    Hybridoma; 1995 Apr; 14(2):167-74. PubMed ID: 7590775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to murine monoclonal antibody-B43.13 correlate with prolonged survival of women with recurrent ovarian cancer.
    Möbus VJ; Baum RP; Bolle M; Kreienberg R; Noujaim AA; Schultes BC; Nicodemus CF
    Am J Obstet Gynecol; 2003 Jul; 189(1):28-36. PubMed ID: 12861134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are human anti-idiotypic anti-OC125 antibodies formed after immunization with the anti-CA125 antibody B43.13?
    Reinsberg J; Krebs D
    Hybridoma; 1997 Feb; 16(1):59-63. PubMed ID: 9085130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of immunological responses in patients with ovarian cancer treated with the anti-idiotype vaccine ACA125 by determination of intracellular cytokines--a preliminary report.
    Reinartz S; Boerner H; Koehler S; Von Ruecker A; Schlebusch H; Wagner U
    Hybridoma; 1999 Feb; 18(1):41-5. PubMed ID: 10211787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres.
    Ma J; Samuel J; Kwon GS; Noujaim AA; Madiyalakan R
    Cancer Immunol Immunother; 1998 Sep; 47(1):13-20. PubMed ID: 9755874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiidiotypic antibodies in ovarian cancer patients treated with the monoclonal antibody B72.3.
    Schmolling J; Reinsberg J; Wagner U; Krebs D
    Hybridoma; 1995 Apr; 14(2):183-6. PubMed ID: 7590777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional mimicry of an anti-idiotypic antibody to nominal antigen on cellular response.
    Ma J; Zhou L; Wang D
    Jpn J Cancer Res; 2002 Jan; 93(1):78-84. PubMed ID: 11802811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and expression of a single chain antibody mimicing human ovarian cancer antigen CA125.
    Li AD; Li Z; Wang YH; Zhang YM; Ma J
    Cell Mol Immunol; 2006 Feb; 3(1):59-62. PubMed ID: 16549051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001.
    Wagner U; Köhler S; Reinartz S; Giffels P; Huober J; Renke K; Schlebusch H; Biersack HJ; Möbus V; Kreienberg R; Bauknecht T; Krebs D; Wallwiener D
    Clin Cancer Res; 2001 May; 7(5):1154-62. PubMed ID: 11350879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients.
    Gordon AN; Schultes BC; Gallion H; Edwards R; Whiteside TL; Cermak JM; Nicodemus CF
    Gynecol Oncol; 2004 Aug; 94(2):340-51. PubMed ID: 15297171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies and idiotypic network activation for ovarian carcinoma.
    Wagner U; Reinsberg J; Schmidt S; Mallmann P; Schmolling J; Schultes B; Richter H; Biersack HJ; Krebs D
    Cell Biophys; 1994; 24-25():237-42. PubMed ID: 7736528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of human ovarian carcinoma with OvaRex MAb-B43.13 in a human-PBL-SCID/BG mouse model.
    Schultes BC; Zhang C; Xue LY; Noujaim AA; Madiyalakan R
    Hybridoma; 1999 Feb; 18(1):47-55. PubMed ID: 10211788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
    Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
    Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OVAREX MAb-B43.13:IFN-gamma could improve the ovarian tumor cell sensitivity to CA125-specific allogenic cytotoxic T cells.
    Madiyalakan R; Yang R; Schultes BC; Baum RP; Noujaim AA
    Hybridoma; 1997 Feb; 16(1):41-5. PubMed ID: 9085127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of anti-idiotypic (ab2) and anti-anti-idiotypic (ab3) antibodies in patients treated with the mouse monoclonal antibody 17-1A (ab1). Relation to the clinical outcome--an important antitumoral effector function?
    Frödin JE; Faxas ME; Hagström B; Lefvert AK; Masucci G; Nilsson B; Steinitz M; Unger P; Mellstedt H
    Hybridoma; 1991 Aug; 10(4):421-31. PubMed ID: 1937495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.